[ad_1]
BRASILIA – The federal government reported that it is negotiating an extension of the deadline to formalize the eventual entry of Brazil into the international vaccine alliance against Covid-19, the Covax Facility. The deadline ends this Friday, but, like other countries, Brazil asks for more time to analyze.
Search for: Coronavirus May Persist For More Than One Month, Study Finds
According to a note from the government’s Special Communication Secretariat (Secom), Brazil wants “to have more information on the conditions for regulatory approval, the applicable legal instrument, the vaccines under development, their storage and characteristics of logistical transport.” “These definitions are especially important in a country like Brazil, with continental dimensions,” the statement said.
The Covax Facility is an international consortium, coordinated by the World Health Organization (WHO) in association with other entities, to promote multilateral agreements that accelerate the production and distribution of a vaccine against Covid-19. Nine clinical analysis options are currently under the initiative.
The Brazilian government reports that it “carefully studies Brazil’s participation in the Covax Facility” and that its “premise is to ensure fair and equitable access to safe and effective vaccines for the protection of the Brazilian population against the new coronavirus” in international treaties has been doing.
Threat:Obesity is as important a risk factor as advanced age for exacerbation and death from the disease.
“Since June, the Brazilian government has been part of the ACT-Accelerator, a multilateral initiative that aims to accelerate the development, production and access to diagnostics, drugs, treatments, tests and, above all, vaccines against Covid-19,” said the Secom note. ACT-Accelerator is short for “Access to Covid-19 Tools Accelerator”, Covid’s broader global coalition. Covax Facility is the ACT-Accelerator arm for vaccines.
The government statement, however, does not detail what factors still weigh in in decision-making. Internally, the group opposed to the adhesion points out that Brazil has already signed the support for the Oxford vaccine, although they are aware that they should not invest in a single investigation.
Another argument that has led the government to be cautious is the risk of financial commitments derived from accession. Officials from the Planalto Palace and the Ministry of Health have met to discuss what to do with the consortium.
On the 24th, the WHO announced that 172 economies participated in talks to potentially participate in Covax. There was a timeline for confirming membership until formal association, with a September 18 deadline, the organization said.
